Literature DB >> 16697327

Clinical outcome of 193 extracardiac Fontan patients: the first 15 years.

Salvatore Giannico1, Fatma Hammad, Antonio Amodeo, Guido Michielon, Fabrizio Drago, Attilio Turchetta, Roberto Di Donato, Stephen P Sanders.   

Abstract

OBJECTIVES: We sought to evaluate the mid-term outcome of hospital survivors with extracardiac Fontan circulation.
BACKGROUND: Few data exist about the mid-term and long-term results of the extracardiac Fontan operation.
METHODS: From November 1988 to November 2003, 221 patients underwent an extracardiac Fontan procedure as primary (9 patients) or secondary (212 patients) palliation, at a mean age of 72.2 months (range 13.1 to 131.3 months). A total of 165 of 193 early survivors underwent programmed noninvasive follow-up evaluations and at least one cardiac catheterization.
RESULTS: The overall survival, including operative deaths, was 85% at 15 years. Freedom from late failure among hospital survivors is 92% at 15 years. A total of 127 of 165 survivors (77%) were in New York Heart Association functional class I. The incidence of late major problems was 24% (42 major problems in 36 of 165 patients): 19 patients had arrhythmias (11%), 5 patients had obstruction of the extracardiac conduit (3%) and 6 of the left pulmonary artery (3.5%), and 5 patients experienced ventricular failure (3%), leading to heart transplantation in 3 patients. Protein-losing enteropathy was found in two patients (1%). The incidence of late re-interventions was 12.7% (21 of 165 patients, including 15 epicardial pacemaker implantations). Four patients died (2.3%), two after heart transplantation.
CONCLUSIONS: After 15 years of follow-up, the overall survival, the functional status, and the cardiopulmonary performance of survivors of the extracardiac Fontan procedure compare favorably with other series of patients who underwent the lateral tunnel approach. The incidence of late deaths, obstructions of the cavopulmonary pathway, re-interventions, and arrhythmias is lower than that reported late after other Fontan-type operations.

Entities:  

Mesh:

Year:  2006        PMID: 16697327     DOI: 10.1016/j.jacc.2005.12.065

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  41 in total

Review 1.  Tissue-engineered vascular grafts for use in the treatment of congenital heart disease: from the bench to the clinic and back again.

Authors:  Joseph T Patterson; Thomas Gilliland; Mark W Maxfield; Spencer Church; Yuji Naito; Toshiharu Shinoka; Christopher K Breuer
Journal:  Regen Med       Date:  2012-05       Impact factor: 3.806

2.  Effects of transcatheter closure of Fontan fenestration on exercise tolerance. kidecho@yahoo.com.

Authors:  Tarek S Momenah; Haifa Eltayb; Reida El Oakley; Howeida Al Qethamy; Yahya Al Faraidi
Journal:  Pediatr Cardiol       Date:  2007-12-11       Impact factor: 1.655

3.  Exercise performance after surgery for pulmonary atresia and intact ventricular septum.

Authors:  Britt-Marie Ekman-Joelsson; Per M Gustafsson; Jan Sunnegårdh
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

4.  Intermediate-Term Results After Extracardiac Conduit Fontan Palliation in Children and Young Adults with Single Ventricle Physiology-A Single-center Experience.

Authors:  Shashi Raj; Eliot Rosenkranz; Barbara Sears; Sethuraman Swaminathan
Journal:  Pediatr Cardiol       Date:  2016-05-09       Impact factor: 1.655

Review 5.  Fontan Operation: Indications, Short and Long Term Outcomes.

Authors:  P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2015-06-20       Impact factor: 1.967

Review 6.  Extracardiac conduit Fontan procedure versus intra-atrial lateral tunnel Fontan procedure.

Authors:  Toshiyuki Katogi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-10-18

7.  Meta-analysis of Fontan procedure : Extracardiac conduit vs. intracardiac lateral tunnel.

Authors:  J Zheng; Z Li; Q Li; X Li
Journal:  Herz       Date:  2017-03-24       Impact factor: 1.443

Review 8.  Tissue-engineered vascular grafts for congenital cardiac disease: Clinical experience and current status.

Authors:  Joseph D Drews; Hideki Miyachi; Toshiharu Shinoka
Journal:  Trends Cardiovasc Med       Date:  2017-06-21       Impact factor: 6.677

9.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: complex congenital cardiac lesions.

Authors:  Candice K Silversides; Omid Salehian; Erwin Oechslin; Markus Schwerzmann; Isabelle Vonder Muhll; Paul Khairy; Eric Horlick; Mike Landzberg; Folkert Meijboom; Carole Warnes; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

10.  Correlation Between Cardiopulmonary Exercise Test, Spirometry, and Congenital Heart Disease Severity in Pediatric Population.

Authors:  Natalia Morales Mestre; Gregory Reychler; Christophe Goubau; Stéphane Moniotte
Journal:  Pediatr Cardiol       Date:  2019-03-08       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.